Novel aerosol formulation containing a polar fluorinated molecule
申请人:——
公开号:US20030194378A1
公开(公告)日:2003-10-16
The present invention relates to a stable pharmaceutical aerosol formulation intended for inhalation. The formulation contains an active substance, an aerosol propellant, a polar flurorinated molecule and an excipient. The preferred propellant is HFA 134a or HFA 227 or a mixture thereof.